KOMORBID (HIPERTENSI, DIABETES MELLITUS, PENYAKIT KARDIOVASKULAR) DAN KEMATIAN PASIEN COVID-19
Abstract Views:
61 times
PDF Downloads:
79 times
Abstract
Abstract—COVID-19 is a disease caused by SARS-CoV-2. Indonesia recorded a total 2,455,912 cases with 64,631 deaths on July 9, 2021. The prevalence in Blitar Regency was 6661 cases with 852 deaths. COVID-19 with comorbidities have risk of falling into severe conditions. The purpose of this study is to determine the relationship between comorbidities and mortality rate of COVID-19 patients at Ngudi Waluyo Hospital, Blitar Regency, April 2020–September 2021. This research is descriptive retrospective with univariate and bivariate analysis. The sample size used total sampling of 677 patients. The distribution of patients died from COVID19 with comorbidities (cardiovascular disease, hypertension, diabetes mellitus) found the highest distribution in 51-60 age group (29.5%), female(51%), working (82.1%). Distribution by comorbid: COVID-19 with comorbidities (78.9%), cardiovascular disease (32.8%), hypertension (30%), diabetes mellitus (16.1%). The result showed a significant relationship between comorbidities (p=0.000), cardiovascular disease (p=0.000), hypertension (p=0.000), diabetes mellitus (p=0.000) and mortality rate of COVID-19. Most of the patients who died from COVID-19 were women aged 51-60 years, worked. There was a weak correlation between the distribution of comorbid cardiovascular disease, hypertension, and diabetes mellitus with the mortality rate of COVID-19 patients and moderate correlation between comorbid with mortality rate of COVID-19 patients.
Keywords: blitar regency, comorbid, covid-19, death
Abstrak—COVID-19 disebabkan oleh virus SARS-CoV-2. Indonesia terdapat 2,455,912 kasus konfirmasi dengan 64,631 kematian pada 9 Juli 2021. Kabupaten Blitar terdapat 6661 kasus konfirmasi dengan 852 kematian. Pasien COVID-19 disertai komorbid memiliki resiko untuk jatuh ke kondisi yang lebih parah. Penelitian ini bertujuan untuk mengetahui hubungan komorbid dengan angka kematian COVID-19 di RSUD Ngudi Waluyo Kabupaten Blitar Periode Bulan April 2020–September 2021. Penelitian ini bersifat deskriptif retrospektif dengan analisa univariat dan bivariat. Besar sampel menggunakan total sampling sebanyak 677 pasien. Distribusi proporsi pasien meninggal COVID19 dengan komorbid (hipertensi, diabetes Mellitus, penyakit kardiovaskular) di RSUD Ngudi Waluyo Kabupaten Blitar periode Bulan April 2020 – September 2021 ditemukan distribusi tertinggi pada umur 51-60 (29,5%), perempuan (51%), bekerja (82,1%). Distribusi berdasarkan komorbid : COVID-19 meninggal dengan komorbid (78,9%), penyakit kardiovaskular (32,8%), hipertensi (30%), diabetes mellitus (16,1%). Hasil uji statistik didapatkan hubungan signifikan antara komorbid (p=0,000), penyakit kardiovaskular (p=0,000), hipertensi (p=0,000), diabetes mellitus (p=0,000) dengan angka kematian pasien COVID-19. Penelitian ini menunjukkan bahwa pasien meninggal COVID-19 banyak pada perempuan usia 51-60 tahun, bekerja. Terdapat korelasi lemah antara distribusi komorbid penyakit kardiovaskular, hipertensi, diabetes mellitus dengan angka kematian pasien COVID-19. Didapatkan korelasi sedang antara distribusi komorbid dengan angka kematian pasien COVID-19.
Kata Kunci: covid-19, kabupaten blitar , kematian, komorbid
Downloads
References
Akbarshakh Akhmerov and Eduardo Marbán. (2020). COVID-19 and the Heart. Circulation research, 126(10), pp.1443-1455.
Alfhad H, Saftarina F, Kurniawan B, et al. (2020).Dampak Infeksi SARS-Cov-2 Terhadap Penderita Hipertensi. Majority Medical Journal Of Lampung University. 2020;9 (April):1-5
Bajgain, K. T., Badal, S., Bajgain, B. B., & Santana, M. J. (2020). Prevalence of comorbidities among individuals with COVID-19: A rapid review of current literature. American Journal of Infection Control, 49(2), 238–246. https://doi.org/10.1016/j.ajic.2020.06.213
Dhama, K., Khan, S., Tiwari, R., Sircar, S., Bhat, S., Malik, Y. S., Singh, K. P., Chaicumpa, W., Bonilla- Aldana, D. K., & Rodriguez-Morales, A. J. (2020). Coronavirus Disease 2019-COVID-19. Clinical microbiology reviews, 33(4), e00028-20. https://doi.org/10.1128/CMR.00028-20
Ejaz, H., Alsrhani, A., Zafar, A., Javed, H., Junaid, K., Abdalla, A. E., Abosalif, K., Ahmed, Z., & Younas, S. (2020). COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of infection and public health, 13(12), 1833–1839. https://doi.org/10.1016/j.jiph.2020.07.014
Elemam, N. M., Hannawi, H., Salmi, I. A., Naeem, K. B., Alokaily, F., & Hannawi, S. (2021). Diabetes mellitus as a comorbidity in COVID-19 infection in the United Arab Emirates. Saudi medical journal, 42(2), 170–180. https://doi.org/10.15537/smj.2021.2.25700
Espinosa, O. A., Zanetti, A., Antunes, E. F., Longhi, F. G., Matos, T. A., & Battaglini, P. F. (2020). Prevalence of comorbidities in patients and mortality cases affected by SARS-CoV2: a systematic review and meta-analysis. Revista do Instituto de Medicina Tropical de Sao Paulo, 62, e43. https://doi.org/10.1590/S1678-9946202062043
Ge E, Li Y, Wu S, Candido E, Wei X. (2021). Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study. PLOS ONE 16(10): e0258154. https://doi.org/10.1371/journal.pone.0258154
Guo, W., Li, M., Dong, Y., Zhou, H., Zhang, Z., Tian, C., Qin, R., Wang, H., Shen, Y., Du, K., Zhao, L., Fan, H., Luo, S., & Hu, D. (2020). Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes/metabolism research and reviews, 36(7), e3319. Advance online publication. https://doi.org/10.1002/dmrr.3319
Handayani, D., Hadi, D., Isbaniah, F., Burhan, E., & Agustin, H. (2020).Corona Virus Disease 2019. Jurnal Respirologi Indonesia, 40(2), 119-129.doi:https://doi.org/10.36497/jri.v40i2.101
Hasanah Nurul. (2020). Analisis Prevalensi Komorbid Dengan Kematian Pasien COVID-19 di Kabupaten Bangkalan (Studi di wilayah Dinas Kesehatan Kabupaten Bangkalan). STIKes Ngudia Husada Madura.
Hasanah, D. Y., Nauli, S., Prima Putri, V., Arifianto, H., Suryana, N., Suryani, L., Aditya, W., & Probodewi, P. (2020). Gangguan Kardiovaskular pada Infeksi COVID 19. Indonesian Journal of Cardiology, 41(2), 60-9. https://doi.org/10.30701/ijc.994
Kementrian Kesehatan Republik Indonesia. (2020). Pedoman Pencegahan dan Pengendalian CoronaVirus Disease (COVID-19). Jakarta: Kemenkes RI.
Kotlyar, A. M., Grechukhina, O., Chen, A., Popkhadze, S., Grimshaw, A., Tal, O., Taylor, H. S., & Tal,R. (2021). Vertical transmission of coronavirus disease 2019: a systematic review and meta- analysis. American journal of obstetrics and gynecology, 224(1), 35–53.e3. https://doi.org/10.1016/j.ajog.2020.07.049
Koya, S. F., Ebrahim, S. H., Bhat, L. D., Vijayan, B., Khan, S., Jose, S. D., Pilakkadavath, Z., Rajeev, P., & Azariah, J. L. (2021). COVID-19 and Comorbidities: Audit of 2,000 COVID-19 Deaths in India. Journal of epidemiology and global health, 11(2), 230–232. https://doi.org/10.2991/jegh.k.210303.001
Lavan, A. H., & Gallagher, P. (2016). Predicting risk of adverse drug reactions in older adults. Therapeutic advances in drug safety, 7(1), 11–22. https://doi.org/10.1177/2042098615615472
Lippi, G., Wong, J., & Henry, B. M. (2020). Hypertension in patients with coronavirus disease 2019 (COVID-19): a pooled analysis. Polish archives of internal medicine, 130(4), 304–309. https://doi.org/10.20452/pamw.15272
Liu, W., Tao, Z. W., Wang, L., Yuan, M. L., Liu, K., Zhou, L., Wei, S., Deng, Y., Liu, J., Liu, H. G., Yang, M., & Hu, Y. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease. Chinese medical journal, 133(9), 1032–1038.
Nugraha, B., Wahyuni, L. K., Laswati, H., Kusumastuti, P., Tulaar, A. B., & Gutenbrunner, C. (2020). COVID-19 pandemic in Indonesia: Situation and challenges of rehabilitation medicine in Indonesia. Acta medica Indonesiana, 52(3), 299–305.
Rao, S., Lau, A., & So, H. C. (2020). Exploring Diseases/Traits and Blood Proteins Causally Related to Expression of ACE2, the Putative Receptor of SARS-CoV-2: A Mendelian Randomization Analysis Highlights Tentative Relevance of Diabetes-Related Traits. Diabetes care, 43(7), 1416–1426. https://doi.org/10.2337/dc20-0643
Shi, Q., Zhang, X., Jiang, F., Zhang, X., Hu, N., Bimu, C., Feng, J., Yan, S., Guan, Y., Xu, D., He, G., Chen, C., Xiong, X., Liu, L., Li, H., Tao, J., Peng, Z., & Wang, W. (2020). Clinical Characteristics and Risk Factors for Mortality of COVID-19 Patients With Diabetes in Wuhan, China: A Two- Center, Retrospective Study. Diabetes care, 43(7), 1382–1391. https://doi.org/10.2337/dc20-0598
Wang, C., Wang, Z., Wang, G., Lau, J. Y., Zhang, K., & Li, W. (2021). COVID-19 in early 2021: current status and looking forward. Signal transduction and targeted therapy, 6(1), 114. https://doi.org/10.1038/s41392-021-00527-1
Wang, D., Hu, B., Hu, C., Zhu, F., Liu, X., Zhang, J., Wang, B., Xiang, H., Cheng, Z., Xiong, Y., Zhao, Y., Li, Y., Wang, X., & Peng, Z. (2020). Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China. JAMA, 323(11), 1061–1069. https://doi.org/10.1001/jama.2020.1585
WHO. (2020). Media Statement: Knowing the risks for COVID-19. Diakses pada 5 juli 2021 dari https://www.who.int/indonesia/news/detail/08-03-2020-knowing-the-risk-for-covid-19
WHO. (2020). Pertanyaan dan jawaban terkait Coronavirus. Diakses pada 5 juli 2021 dari https://www.who.int/indonesia/news/novel-coronavirus/qa/qa-for-public
Willim, H.A., Ketaren, I. and Supit, A.I. (2020). Dampak Coronavirus Disease 2019 terhadap Sistem Kardiovaskular. e-CliniC, 8(2).
Yeo, C., Kaushal, S., & Yeo, D. (2020). Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible?. The lancet. Gastroenterology & hepatology, 5(4), 335– 337. https://doi.org/10.1016/S2468-1253(20)30048-0
Zhang, J., Wang, X., Jia, X., Li, J., Hu, K., Chen, G., Wei, J., Gong, Z., Zhou, C., Yu, H., Yu, M., Lei, H., Cheng, F., Zhang, B., Xu, Y., Wang, G., & Dong, W. (2020). Risk factors for disease severity, unimprovement, and mortality in COVID-19 patients in Wuhan, China. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 26(6), 767–772. https://doi.org/10.1016/j.cmi.2020.04.012
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
- Articles published in CALYPTRA are licensed under a Creative Commons Attribution-ShareAlike 4.0 International license. You are free to copy, transform, or redistribute articles for any lawful purpose in any medium, provided you give appropriate credit to the original author(s) and the journal, link to the license, indicate if changes were made, and redistribute any derivative work under the same license.
- Copyright on articles is retained by the respective author(s), without restrictions. A non-exclusive license is granted to CALYPTRA to publish the article and identify itself as its original publisher, along with the commercial right to include the article in a hardcopy issue for sale to libraries and individuals.
- By publishing in CALYPTRA, authors grant any third party the right to use their article to the extent provided by the Creative Commons Attribution-ShareAlike 4.0 International license.
